AVGO vs KRYS Stock Comparison

KRYS currently leads AVGO in this stock comparison, with AIQ scores of 69 vs 52. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 17 points
AVGO
Technology
vs
KRYS
Healthcare
AVGO
Broadcom Inc.
Price
$347
Day move
-4.76%
AIQ Score
52/100
Best edge
Balanced
Sector
Technology
KRYS
Krystal Biotech, Inc.
Leads
Price
$305
Day move
-0.15%
AIQ Score
69/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between AVGO and KRYS?

KRYS leads the current stock comparison as Krystal Biotech, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs Krystal Biotech, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Technology vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 8/10

KRYS leads

KRYS leads by 17 AIQ points, primarily on Risk Resilience and Momentum. Wall Street currently favors AVGO on target upside.

Stable: 3 of 6 evidence groups support KRYS, and its signal state is cleanly positive.

Evidence agreement: 3 of 6Comparison trend: Stable
AVGO

Broadcom Inc.

AIQ Score
52/100
AIQ Edge Score
7/10
KRYS

Krystal Biotech, Inc.

Leads
AIQ Score
69/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors KRYS over AVGO, 69 versus 52 as of Nov 15, 2026. KRYS's advantage is driven primarily by stronger risk resilience and momentum. KRYS also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 3 of 6 covered evidence groups favor KRYS today, and the comparison is rated Stable on stability: only 3 of 6 covered evidence groups agree. KRYS lead: Stable — the AIQ differential has held near 17 points over 30 sessions. KRYS leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Broadcom Inc. and Krystal Biotech, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+565.5%
KRYS
+521.8%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $66,548 · KRYS $62,178

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and KRYS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
KRYS advantage
  • Risk Resilience47 vs 69
    KRYS +22
  • Momentum40 vs 58
    KRYS +18
  • Value50 vs 67
    KRYS +17
  • Quality69 vs 83
    KRYS +14

3 of 6 evidence groups favor KRYS. KRYS’s edge is concentrated in risk resilience and momentum.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AVGO0 AIQ

Largest factor move: Momentum -2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

KRYS0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • MACD Bullish Crossover — bullish, momentum, short horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

KRYS's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and KRYS both carry a full feed there.

The central trade-off

KRYS (Krystal Biotech, Inc.): the stronger current systematic profile, led by risk resilience and momentum.

AVGO (Broadcom Inc.): the counter-case, on fundamentals, technicals, analyst expectations — but at materially higher volatility, 70% against 47.8%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

KRYS

KRYS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

KRYS

KRYS on the peer-relative Value factor, by 17 points.

Momentum

KRYS

KRYS on the Momentum factor, by 18 points.

Lower downside

KRYS

KRYS on Risk Resilience, by 22 points.

Analyst upside

AVGO

AVGO on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors KRYS, analyst targets favor AVGO. That disagreement is the most useful thing on this page.

MeasureAVGOKRYSNote
Implied upside to target+48.5%+40.4%AVGO has more room
Target dispersion+48.5%+5.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering5112Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor KRYS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreKRYS52 vs 69
FundamentalsAVGOon balancerevenue growth 33.4% vs 6.8%; EPS growth 40.3% vs 15.1%; TTM ROE 13.1% vs 4.4%; gross margin 68.8% vs 93.4%; operating margin 48.4% vs 48.4% — AVGO takes 3 of 4 decided legs, not all of them
ValuationKRYSValue 50 vs 67
TechnicalsAVGOPrice vs 50-day 0.5% vs -6.6%; vs 200-day -5.6% vs -1.4%
Risk ResilienceKRYSRisk Resilience 47 vs 69
Analyst expectationsAVGOTarget upside 48.5% vs 40.4%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and KRYS and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 17 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on KRYS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

KRYS lead: Stable — the AIQ differential has held near 17 points over 30 sessions.

May 27AVGO leads above the line · KRYS leads belowNov 13
Today
KRYS +17
52 vs 69
7 sessions ago
KRYS +22
50 vs 72
30 sessions ago
KRYS +18
55 vs 73
90 sessions ago
KRYS +13
59 vs 72

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • Death Cross Active — bearish, trend, long horizon (6.38%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.18x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
KRYS

3 bullish / 0 bearish / 1 neutral

Only KRYS

  • Golden Cross Active — bullish, trend, long horizon (5.51%)
  • MACD Bullish Crossover — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, MACD Histogram Expanding Bullish.

AVGO is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).

KRYSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.15%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Risk Resilience gap — currently 22 points behind, the largest single contributor to KRYS's edge.
  2. 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGOKRYS
Revenue growth (YoY)33.4%6.8%
EPS growth (YoY)40.3%15.1%
Gross margin68.8%93.4%
Operating margin48.4%48.4%
Return on equity (TTM)13.1%4.4%
Debt to equity0.60.01

Performance

KRYS leads 4 of 6 windows
MetricAVGOKRYS
1 week (5 sessions)18.2%1.4%
1 month (20 sessions)5.6%-3.6%
3 months (63 sessions)-11.6%-9.1%
6 months (126 sessions)-18.4%-0.3%
Year to date0.3%23.8%
1 year (252 sessions)-2.3%50.3%

Technicals

AVGO has the stronger structure
MetricAVGOKRYS
RSI (14)53.243
ADX (14)2318.5
Price vs 50-day0.5%-6.6%
Price vs 200-day-5.6%-1.4%
Volatility (1M, annualized)70%47.8%

Risk

KRYS is the more resilient
MetricAVGOKRYS
Beta2.210.74
Sharpe ratio0.211.16
Sortino ratio0.291.67
Max drawdown-39.5%-21.8%
Current drawdown-27.9%-19.3%
Annualized volatility48.6%39.4%
Value at risk (95%)-4.6%-3.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or KRYS?

On the Algovestiq AIQ Score, KRYS is the stronger of the two as of Nov 15, 2026, scoring 69 against AVGO's 52. The edge comes from risk resilience and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or KRYS the better buy right now?

KRYS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor KRYS over AVGO?

The composite weights Quality, Value, Momentum and Risk Resilience. KRYS leads Risk Resilience by 22 points; KRYS leads Momentum by 18 points; KRYS leads Value by 17 points. KRYS leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by AVGO simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, AVGO or KRYS?

Analyst price targets imply +48.5% upside for AVGO and +40.4% for KRYS, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors KRYS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or KRYS?

KRYS is the better-valued of the two on the peer-relative Value factor. KRYS on the peer-relative Value factor, by 17 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or KRYS?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or KRYS?

KRYS on the Momentum factor, by 18 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or KRYS?

KRYS is the more resilient of the two, so the other name carries the higher downside risk. KRYS on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than KRYS?

The profitability evidence is mixed: gross margin 68.8% vs 93.4%; operating margin 48.4% vs 48.4%; ttm roe 13.1% vs 4.4%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is KRYS's lead over AVGO getting stronger or weaker?

KRYS lead: Stable — the AIQ differential has held near 17 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the AVGO vs KRYS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Risk Resilience gap — currently 22 points behind, the largest single contributor to KRYS's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; KRYS's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AVGO and KRYS?

AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. KRYS: 3 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On KRYS it is Golden Cross Active (bullish, long horizon).

Compare AVGO and KRYS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.